1. Rifaximin-α for liver fibrosis in patients with alcohol-related liver disease (GALA-RIF): a randomised, double-blind, placebo-controlled, phase 2 trial;Israelsen;Lancet Gastroenterol Hepatol,2023
2. Predictors of 90-day mortality in patients with severe alcoholic hepatitis: experience with 183 patients at a tertiary care center from India;Daswani;Indian J Gastroenterol Off J Indian Soc Gastroenterol,2018
3. Rifaximin: an antibiotic with important biologic effects;DuPont;Mini Rev Med Chem,2015
4. The use of rifaximin in patients with cirrhosis;Caraceni;Hepatol Baltim Md,2021
5. Burden of gastrointestinal and liver diseases in India, 1990-2016;Shah;Indian J Gastroenterol Off J Indian Soc Gastroenterol,2018